Allergios
PrivateLast Round
Grant
Oct 10, 2024
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Allergios operates in Healthcare & Life Sciences and is based in Amsterdam. Its latest recorded funding round was a Grant round in October 2024.
Allergios is a medical technology company that develops an AI-powered microfluidic platform for functional allergy diagnostics, aiming to replace traditional oral provocation tests.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Medical Imaging, Medical AI
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Allergios Comparables
Compare Allergios with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bioherent | 81% | |
| BÜHLMANN Laboratories AG | 72% | |
| Thermo Fisher Scientific Inc. | 72% |
For institutional investors. Book with your work email.
Allergios Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 10, 2024 | ||||
| Seed | May 23, 2022 |
For institutional investors. Book with your work email.
Allergios Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NLC Health Ventures | Seed |
| Health~Holland | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 76% MoM, from 296 to 522.
- Jul 25, 2026
Monthly visitors increased 311% MoM.
For institutional investors. Book with your work email.
Allergios Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Allergios's valuation, stock price, and market status.
Is Allergios a public or private company?
Allergios is a private company.
What is the current stock price of Allergios?
Allergios is a private company, so its shares have no public market price. Caplight tracks Allergios's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Allergios worth (valuation)?
Valuation information for Allergios is not publicly available.
Can I buy Allergios stock?
Allergios shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Allergios's last funding round?
Allergios's most recent funding round was Grant on October 10, 2024.
Who are the main investors in Allergios?
Key investors in Allergios include NLC Health Ventures, Health~Holland.
Will Allergios IPO soon?
No public IPO plans have been announced for Allergios.
How can I track Allergios secondary market activity?
Caplight tracks bids, offers, and trades in Allergios's shares on secondary markets.